secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K
Filed at:   2026-05-12T12:48:29+00:00
Accession:  0001193125-26-218282
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coya Therapeutics enters $30M at-the-market equity offering with Leerink Partners
--------------------------------------------------------------------------------

- Sales Agreement with Leerink Partners allows up to $30M gross proceeds from common stock sales on Nasdaq.
- Leerink receives 3.0% commission on gross proceeds; Company may sell at its discretion.
- Offering under existing shelf registration; no minimum obligation to sell.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000119312526218282/0001193125-26-218282-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000119312526218282/d938051d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-218282

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer